Regulatory/GMP Compliance

Feb 01, 2018
BioPharm International
As closure integrity testing moves from a probabilistic to a deterministic basis, designs are promoting improved control and reduced operator contact.
Feb 01, 2018
BioPharm International
Steve Hayward, product marketing manager at BIOVIA, Dassault Systèmes, discusses the importance of both technology and people in the modern laboratory.
Feb 01, 2018
BioPharm International
This article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.
Feb 01, 2018
By BioPharm International Editors
Federal agencies have partnered to develop a roadmap that offers a new framework for the safety testing of drugs and chemicals without the use of animals.
Jan 31, 2018
FDA and industry weigh broader use of prior knowledge in biotechnology testing and production.
Jan 26, 2018
By BioPharm International Editors
The Fluent Gx Automation Workstation from Tecan is suited for a variety of clinical and regulated laboratory applications.
Jan 23, 2018
By BioPharm International Editors
The FDA center released its list of planned guidance documents for the rest of the year.
Jan 23, 2018
By BioPharm International Editors
The latest continuing resolution funds the government for three weeks.
Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 11, 2018
By BioPharm International Editors
The agency is requiring safety label changes to limit the use of prescription opioid cough and cold medicines in children younger than 18 years old.
native1_300x100
lorem ipsum